Avalo Therapeutics
AVTX
AVTX
36 hedge funds and large institutions have $88.3M invested in Avalo Therapeutics in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
34% less capital invested
Capital invested by funds: $133M → $88.3M (-$44.7M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
36
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.42M | |
| 2 | +$589K | |
| 3 | +$305K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$284K |
| 5 |
State Street
Boston,
Massachusetts
|
+$189K |
Top Sellers
| 1 | -$1.48M | |
| 2 | -$605K | |
| 3 | -$413K | |
| 4 |
AI
Atom Investors
Austin,
Texas
|
-$220K |
| 5 |
Renaissance Technologies
New York
|
-$181K |